Voya Investment Management Fund's Quarterly Performance Insights
Finance

Voya Investment Management Fund's Quarterly Performance Insights

authorBy Robert Kiyosaki
DateAug 25, 2026
Read time3 min

This quarter, the Voya Investment Management fund recorded a total return of 19.73% based on net asset value and 19.74% on market price. Despite these gains, the fund lagged its benchmark due to specific investment choices. Underweight allocations to technology giants like MediaTek Inc. and SK Square Co., Ltd., along with the absence of Samsung Electronics Co. Ltd. Pfd Non-Voting from the portfolio, significantly hampered relative performance. Additionally, the fund's option strategy, while generating premiums, constrained upside participation during a period of strong equity market rally, contributing negatively to overall returns. The equity component of the fund was particularly affected by its higher dividend yield exposure and unfavorable stock selection across information technology, financial, and materials sectors.

Voya Investment Management Fund: Navigating Market Dynamics with Mixed Results

In a recent quarterly assessment, Voya Investment Management's fund posted a robust total return of 19.73% on a net asset value basis and 19.74% on a market price basis. Despite this commendable performance, the fund experienced underperformance against its benchmark. A critical factor in this divergence was the fund's strategic underweighting of prominent technology companies, including MediaTek Inc. and SK Square Co., Ltd., and its non-holding of Samsung Electronics Co. Ltd. Pfd Non-Voting. These specific allocation decisions proved detrimental to relative returns. Furthermore, the fund's option strategy, primarily a covered call approach, generated premiums but inadvertently capped potential gains during a period characterized by a strong upward trajectory in the equity market. Within the equity portfolio, the emphasis on higher dividend yield investments and stock selection in the information technology, financial, and materials sectors also contributed to the fund's benchmark underperformance. Conversely, the core investment model, particularly its sentiment and operations pillars, demonstrated positive contributions, highlighting the efficacy of fundamental analysis in certain areas. This quarter's results underscore the intricate balance between strategic positioning and market dynamics.

This quarter's performance offers valuable insights into the complexities of active investment management. While the overall returns were positive, the underperformance against the benchmark serves as a reminder that even well-constructed portfolios can face headwinds from specific market trends or sector movements. The impact of the option strategy highlights a common dilemma: balancing risk reduction and income generation with the potential for limiting upside in a rallying market. For investors, this report reinforces the importance of understanding not only headline returns but also the underlying drivers of performance, including sector allocation, individual stock selection, and derivative strategies. Looking forward, the persistent challenges of geopolitical risks and macroeconomic uncertainty emphasize the need for continued vigilance and adaptable investment approaches. Diversification and a deep understanding of market sectors remain paramount in navigating an ever-evolving global financial landscape.

More Articles
Finance
Dianthus Therapeutics: Pioneering a New Era in Neuromuscular Disorder Treatment
Dianthus Therapeutics is revolutionizing neuromuscular treatment with claseprubart, a drug distinguished by its unique clinical profile and the company's robust financial standing. With approximately $1.2 billion in cash and investments, Dianthus is well-positioned to fund multiple late-stage programs, minimizing future funding risks until 2030. Claseprubart's convenient dosing, selective pathway targeting, and promising early clinical results set it apart, especially following recent competitive shifts in the market. Upcoming milestones include key data readouts from the MoMeNtum MMN and CAPTIVATE Part B trials, alongside Phase 1 data for DNTH212, which are crucial for its valuation.
By Strive MasiyiwaAug 25, 2026
Finance
Loblaw Companies Limited: A Hold Rating Due to Overvaluation Despite Strong Market Position
Loblaw Companies Limited, a leading Canadian grocer, showcases strong market dominance and solid financial growth, particularly in its discount and pharmacy sectors. However, its current trading valuation, significantly above historical averages, suggests overpricing. Despite robust fundamentals, the stock is assessed as a 'Hold' given its elevated price-to-earnings ratio relative to its estimated fair value.
By Lisa JingAug 25, 2026
Finance
Inovio's Future Hinges on FDA Decision for INO-3107
Inovio Pharmaceuticals, a biotech company primarily focused on a single late-stage asset, INO-3107, faces a critical FDA decision on October 30th. The company's financial stability, with a $55 million cash reserve, is sufficient to navigate this pivotal regulatory event. The approval of INO-3107, targeting recurrent respiratory papillomatosis, could lead to rapid commercial growth, while a rejection would necessitate urgent capital raising and significant financial challenges.
By Nouriel RoubiniAug 25, 2026
Finance
Amazon: AI Revenue Concerns and Valuation
This article evaluates Amazon's current market position, reiterating a 'Hold' rating despite robust earnings. It highlights concerns regarding the company's AI revenue, which appears heavily dependent on unprofitable deals, and points to negative free cash flow and significant capital expenditures as potential threats to its near-term intrinsic value. While Amazon's traditional businesses show growth, the high risks associated with its AI investments and unclear profitability raise questions about future upside.
By Strive MasiyiwaAug 25, 2026
Finance
Getty Realty: A Steady Hold with Growth Challenges
Getty Realty (GTY) is rated as a Hold, with its shares considered fairly valued around $32.88 based on multiple valuation methods. Despite strong portfolio quality, with high occupancy and long lease terms, the company faces headwinds from slowing growth in funds from operations and a narrow spread between acquisition yields and capital costs. Additionally, tenant concentration and exposure to car washes present potential risks.
By Robert KiyosakiAug 25, 2026